Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you need help with your Mounjaro treatment, who you contact depends entirely on what you need. Your prescribing pharmacy handles clinical questions, supply, and prescriptions. Eli Lilly, Mounjaro's manufacturer, handles medicine-information queries and adverse-event reporting. The NHS or your GP handles anything connected to your wider health. Knowing which door to knock on saves time and, in urgent situations, matters more than that. Mounjaro is a prescription-only medicine, so every aspect of its use sits within a supervised clinical relationship — not a general customer-service queue.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common reason people look for Mounjaro support is a supply or prescription issue: a pen hasn't arrived, a repeat is due, or a dose review is needed. These questions belong with your prescribing pharmacy, not with the manufacturer. If you're a nume patient, you can find out exactly how Mounjaro customer service works in the UK and reach the aftercare team seven days a week for anything from a delayed delivery to a clinical concern that needs a prescriber's eye.
Dose changes are a clinical decision, not an admin task. A prescriber needs to review your progress before any titration can happen, that review is built into every repeat at how Mounjaro treatment works through a regulated pharmacy, so you're not chasing anyone. If you're unsure whether your current dose is right for you, our page on being a slow responder to tirzepatide covers what the evidence says and when to raise it with your prescriber.
If you're not yet a patient and want to understand the process before starting, what new Mounjaro patients should expect walks through the consultation and first-pen journey step by step. Supply runs through the licensed UK supply chain with Eli Lilly as the manufacturer; availability concerns are handled at pharmacy level, not by calling Lilly directly. If you're wondering whether you need to involve your GP at all, our page covering starting Mounjaro without a GP contact explains what the private prescribing route involves and when GP involvement is or isn't required.
Eli Lilly UK maintains a medical-information service for healthcare professionals and patients who have factual questions about tirzepatide: pharmacology, reported interactions, labelling queries, or how to report a suspected side effect to the manufacturer. You can reach Lilly UK medical information through their UK contact details published on the Lilly website (lilly.com/uk). This line is not a prescribing service and cannot authorise dose changes or issue prescriptions.
The most important channel for reporting any suspected side effect (whether or not it's listed in the leaflet) is the MHRA's Yellow Card scheme. You can report directly as a patient; you don't need to go through a professional. Mounjaro carries a Black Triangle (▼) designation, meaning the MHRA actively encourages reporting to build its post-market safety picture. The pen you keep in the fridge door should always come with the patient information leaflet, keep it, because it carries the batch number you'll need for any report.
For a thorough overview of tirzepatide's clinical profile, the NHS tirzepatide medicines page covers side effects, interactions, and what to tell your doctor before starting, straightforward reading before you reach for a phone.
Severe stomach pain that radiates to the back, signs of a serious allergic reaction, persistent vomiting leading to dehydration, or sudden vision changes are not customer-service matters. They are medical ones. Call NHS 111 or 999 as the severity demands, and tell the clinician you're taking tirzepatide. The MHRA's January 2026 Drug Safety Update for GLP-1 medicines specifically flagged acute pancreatitis as a serious but infrequent effect, severe, persistent abdominal pain is the key warning sign, and it warrants urgent assessment, not a wait-and-see approach.
If you're uncertain whether a symptom is serious, NHS 111 is the right first call. Our frequently asked questions cover common side effects and when to escalate, but they are not a substitute for clinical advice. The distinction matters: a customer-service team can track a parcel or resend paperwork; they cannot assess a clinical symptom.
A question our prescribers hear regularly is whether online pharmacies offer any real aftercare or are simply a convenient order point. At a regulated service like nume, every repeat order is clinically reviewed before dispatch by a GPhC-registered Independent Prescriber, a named clinician reads your notes, not software scanning a tick-box. That review is where clinical questions get answered, not routed to a call centre.
You can verify any online pharmacy's registration on the GPhC pharmacy register, a two-second check that tells you whether the people dispensing your medicine are accountable to a statutory regulator. nume's GPhC premises registration is 9012878, publicly verifiable there. If you're weighing up whether a private prescription service is the right route for you, the cost and what it includes is a reasonable starting point, followed by checking your eligibility with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.